Scarica l'app Stockscreener
180.89
0.55%
-1.00
Pre-mercato:
180.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$181.89
Aprire:
$181.52
Volume 24 ore:
745.30K
Relative Volume:
0.78
Capitalizzazione di mercato:
$20.23B
Reddito:
$10.52B
Utile/perdita netta:
$999.00M
Rapporto P/E:
21.63
EPS:
8.3628
Flusso di cassa netto:
$1.22B
1 W Prestazione:
-0.65%
1M Prestazione:
-0.90%
6M Prestazione:
+13.20%
1 anno Prestazione:
+21.58%
Intervallo 1D:
$178.54
$181.62
Intervallo di 1 settimana:
$177.39
$184.48
Portata 52W:
$146.91
$191.49
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Confronta DGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
180.89 | 20.34B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
536.19 | 203.60B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
204.96 | 149.49B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
629.91 | 50.19B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
140.81 | 39.28B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
200.60 | 34.15B | 15.70B | 1.24B | 2.01B | 6.9036 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Ripresa | Evercore ISI | In-line |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-29 | Iniziato | Piper Sandler | Neutral |
| 2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-01-23 | Iniziato | Evercore ISI | In-line |
| 2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-23 | Downgrade | UBS | Buy → Neutral |
| 2022-02-02 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
| 2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Downgrade | Goldman | Neutral → Sell |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-03-18 | Ripresa | Credit Suisse | Neutral |
| 2019-01-31 | Downgrade | Argus | Buy → Hold |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Trend analysis for Quest Diagnostics Incorporated this weekJuly 2025 Setups & Expert Curated Trade Setups - newser.com
Bar Harbor Wealth Management Invests $2.73 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Janney Montgomery Scott LLC Has $3.62 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Evercore ISI Group Raises Price Target for Quest Diagnostics (DG - GuruFocus
Quest Diagnostics (NYSE:DGX) Price Target Raised to $190.00 - MarketBeat
Evercore ISI Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains In Line Rating - MarketScreener
Leerink Partners Adjusts Price Target on Quest Diagnostics to $203 From $192, Maintains Outperform Rating - MarketScreener
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollarMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Will Quest Diagnostics Incorporated stock hit analyst forecastsInsider Buying & Real-Time Market Trend Scan - newser.com
Is Quest Diagnostics Incorporated (QDI) stock a top pick for value investorsJuly 2025 Movers & Low Drawdown Momentum Ideas - newser.com
2,014 Shares in Quest Diagnostics Incorporated $DGX Purchased by Gratus Wealth Advisors LLC - MarketBeat
Appleton Partners Inc. MA Boosts Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 2,526 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
OLD National Bancorp IN Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics Incorporated stock could rally stronglyJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Will Quest Diagnostics Incorporated continue its uptrend2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
How Quest Diagnostics Incorporated (QDI) stock responds to job market shiftsWeekly Risk Report & Stepwise Entry/Exit Trade Alerts - newser.com
Quest Diagnostics Incorporated stock daily chart insightsJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Quest Diagnostics: Investing In Healthcare's Future Today (NYSE:DGX) - Seeking Alpha
How Quest Diagnostics Incorporated (QDI) stock behaves in tightening cycles2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Evaluating Quest Diagnostics Incorporated with trendline analysis2025 Price Momentum & Smart Money Movement Tracker - newser.com
Technical analysis overview for Quest Diagnostics Incorporated stockTrade Risk Report & Community Consensus Stock Picks - newser.com
What to expect from Quest Diagnostics Incorporated in the next 30 daysWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
74,250 Shares in Quest Diagnostics Incorporated $DGX Bought by Boston Common Asset Management LLC - MarketBeat
QRG Capital Management Inc. Buys 11,008 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated stock sustain breakout momentumEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
J. Safra Sarasin Holding AG Grows Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
Copeland Capital Management LLC Has $31.66 Million Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics Incorporated (QDI) stock moves in volatile trading sessionsJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Analyzing Quest Diagnostics Incorporated with multi timeframe chartsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
State of Alaska Department of Revenue Has $2.25 Million Stock Position in Quest Diagnostics Incorporated $DGX - Defense World
Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq
Quest Diagnostics Hits New 52-Week High of $189.23, Reflecting Strong Performance - Markets Mojo
Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News - GuruFocus
Barclays Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains Equalweight Rating - MarketScreener
USA Financial Formulas Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
1,532 Shares in Quest Diagnostics Incorporated $DGX Acquired by GC Wealth Management RIA LLC - MarketBeat
Quest Diagnostics Hits New 52-Week High at $191.45, Surges 34.71% - Markets Mojo
Pack Health closing in Birmingham, nearly 100 people to be laid off - CBS 42
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing - Yahoo Finance
Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life - Nasdaq
350,000 Members Waitlisted: WHOOP's New Blood Testing Platform Combines Lab Work with 24/7 Wearable Data - Stock Titan
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.92%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):